What is the recommended treatment for trichomoniasis in adults and adolescents, including pregnant patients and those with allergies to metronidazole or tinidazole?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 25, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Trichomoniasis

The preferred first-line treatment for trichomoniasis is metronidazole 500mg orally twice daily for 7 days, as this regimen demonstrates superior cure rates compared to single-dose therapy. 1, 2

Standard Treatment Regimens

First-Line Therapy

  • Metronidazole 500mg orally twice daily for 7 days is the optimal regimen, achieving cure rates of approximately 89% compared to 81% with single-dose therapy 2
  • The CDC accepts metronidazole 2g orally as a single dose as an alternative when patient compliance with multi-day therapy is unreliable, when directly observed therapy can be provided, or when cost is a significant barrier 3
  • Single-dose therapy achieves cure rates of 90-95% but has higher failure rates than the 7-day regimen 1, 2

Alternative Agent

  • Tinidazole 2g orally as a single dose is FDA-approved for trichomoniasis and demonstrates equivalent efficacy to metronidazole single-dose therapy 4, 5
  • Tinidazole should be reserved for patients with metronidazole intolerance or treatment failure 4

Critical Management Principles

Partner Treatment (Essential for Success)

  • All sexual partners must be treated simultaneously with the same regimen, regardless of symptoms or testing status 1, 3, 6
  • Most infected men are asymptomatic carriers, making them unknowing vectors of transmission 3
  • Failure to treat partners is the single most common cause of treatment failure and reinfection 1, 3
  • Patients must abstain from sexual intercourse until both partners complete treatment and are asymptomatic 1, 3

Alcohol Avoidance

  • Patients must avoid all alcohol during treatment and for at least 24 hours after the last dose to prevent severe disulfiram-like reactions 3

Management of Treatment Failure

Stepwise Approach

  1. First treatment failure: Re-treat with metronidazole 500mg twice daily for 7 days 1, 3
  2. Second treatment failure: Administer metronidazole 2g once daily for 3-5 days 1, 3
  3. Persistent failure: Consult infectious disease specialist for susceptibility testing after excluding reinfection 1, 3

Common Pitfall

  • Always exclude reinfection from untreated partners before escalating therapy 1

Special Populations

Pregnancy

  • Metronidazole is absolutely contraindicated during the first trimester of pregnancy due to concerns about fetal organogenesis, as the drug crosses the placental barrier rapidly 3, 6
  • After the first trimester, treat with metronidazole 2g orally as a single dose (not the 7-day regimen) to minimize total fetal drug exposure 1, 3
  • If symptomatic trichomoniasis presents during the first trimester, treatment must be delayed until the second trimester begins 3
  • Treatment after the first trimester is warranted because trichomoniasis is associated with premature rupture of membranes and preterm delivery 1, 3

HIV-Infected Patients

  • HIV-infected patients should receive the same treatment regimen as HIV-negative patients 3
  • Bacterial vaginosis does not significantly modify treatment efficacy in HIV-uninfected women 2

Critical Pitfalls to Avoid

Ineffective Therapies

  • Topical metronidazole gel is NOT effective for trichomoniasis and should never be used, achieving less than 50% efficacy 1, 3
  • Other topical antimicrobials have even lower cure rates (<50%) and should be avoided 3
  • Intravaginal metronidazole suppositories, even at high doses (750mg), are not recommended as first-line therapy 7

Follow-Up

  • Follow-up is unnecessary for patients who become asymptomatic after treatment or who are initially asymptomatic 3
  • Test-of-cure should be performed only if symptoms persist or reinfection is suspected 3

Side Effects

  • The most common side effects are nausea (23%), headache (7%), and vomiting (4%) 2
  • Side effects occur with similar frequency between single-dose and 7-day regimens 2, 8
  • Side effects are generally mild and well-tolerated 8, 9

References

Guideline

Treatment of Trichomoniasis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Treatment and Prevention of Trichomoniasis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Single dose treatment of trichomoniasis.

The Journal of international medical research, 1982

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.